<div id="readability-page-1"><div><p>India's healthcare sector, once modest, towers as one of the nation's largest revenue and employment engines. Anchored by expanding coverage and public and private spending, hospitals and ancillary services grow. Friendly FDI rules, generous tax incentives, and a public-private push have lured PE, VCs and foreign firms chasing demand. The hospital market reached 126 billion US dollars in FY 24 and is projected to grow at an 8% CAGR to USD 193.6bn by FY 32, signaling a sustained runway for scale and modernization.</p><p> The future growth narrative is further strengthened by rising healthcare spending, expected to move from 3.3% of GDP to 5% by 2030, and a booming digital health ecosystem. India's digital health market is projected to soar to USD 47.8bn by 2033 at a rapid 17.7% CAGR.</p><p> Opportunities follow suit: healthcare investments reached USD 572m in Q2 CY 25, demand for medical professionals is set to double by 2030, lifestyle diseases now dominate inpatient spending, and telemedicine, powered by AI, remote diagnostics, and smart hospitals is reshaping care delivery.</p><p> Amid this accelerating industry momentum, Fortis Healthcare stands as a pan regional, integrated care provider, blending hospitals and diagnostics into a seamless patient experience. Its portfolio spans inpatient and outpatient services, pathology, radiology, and specialties ranging from cardiac sciences and oncology to orthopedics, neurosurgery, and transplants.</p><p> With around 28 facilities, nearly 4,500 beds, and 400plus diagnostic centers across India, the UAE, Nepal, and Sri Lanka, Fortis delivers scale, specialty depth, and consistent, patient first healthcare.</p><h2> Growth in full pulse</h2><p> Adding numbers to the tale: Over Q2 26, consolidated revenue hit INR 23.3bn, up 17.3% y/y, fueled largely by the Hospital business, which accounts for the majority of sales, surging 19.3% y/y while diagnostics business climbed 7.1% y/y. Management credits a 13% increase in occupied beds, a 36% y/y growth in international patients and fresh customer touch points for keeping the growth engines turning.</p><p> The headline gains cascaded through margins. Operating EBITDA expanded 28% y/y to INR 5.6bn, thanks to leaner costs and fuller capacity, driving a 200bp lift in the EBITDA margin to 23.9%. Net income leapt 70.3% y/y to INR 3.2bn, and EPS rose to INR 4.3, reinforcing the narrative of premium performance.</p><p> The hospital occupancy rate lingered at 71%, down 100bp versus Q2 25, but Average Revenue per Occupied Bed ticked up to INR 25m per annum from INR 24m last year, suggesting service mix improvements even as a slight softening in utilization occurs.</p><h2> Bullish signals</h2><p> Riding this growth momentum, the company's stock handed investors robust returns of 36.6%, pushing market capitalization to INR 677bn (USD 7.5bn). Those gains come with a premium, as the shares now trade at a forward P/E of 60.8x on 2026 earnings, well above the three-year average of 51.5x.</p><p> Yet analysts appear undeterred, tilting heavily toward optimism. Twelve 'Buy' calls line up against four 'Hold' assessments, giving an average target of INR 1,067.8. That consensus points to an upside of 19.1% from today's levels, signaling continuing faith in the narrative and momentum ahead.</p><h2> Momentum with a monitor</h2><p> Fortis Healthcare’s recent run looks more like a story of discipline than a burst of luck. It has steadily filled beds, expanded services and kept up with patient expectations while letting the numbers tell a tale of improved profitability and confidence.</p><p>Yet every high-growth narrative carries its own cautionary subtext. Sustaining elevated investor expectations will require navigating rising competition, potential cost pressures, and the delicate balance of scaling while maintaining care standards. Any hiccup in quality could temper the current momentum. For now, the company’s mix of scale, specialty reach and spirited execution keeps it in a favorable light but watching how it handles the industry’s growing complexity will determine whether the story keeps its shine.</p></div></div>

34962G208

<p>Fortis Healthcare 在印度不斷擴大的醫療保健行業中蓬勃發展，該行業預計將顯著增長，到 FY 32 時將達到 1936 億美元。該公司報告了 2026 財年第二季度收入增長 17.3%，達到 233 億印度盧比，主要得益於其醫院業務。淨收入激增 70.3%，達到 32 億印度盧比，股票表現強勁，回報率為 36.6%。分析師們保持樂觀，普遍目標價為 1,067.8 印度盧比，表明有 19.1% 的上漲空間。然而，持續增長將需要對競爭和質量標準進行謹慎管理</p>

Fortis Healthcare：健康狀況良好